蜂毒肽通过转化生长因子β/SMAD信号通路调控非小细胞肺癌的上皮-间质转化进程*
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

中国民族医药学会科研项目(2019KYXM-Z196-20)


Regulation of melittin on non-small cell lung cancer by TGF-β/SMAD on inhibiting TGF-β-induced EMT process
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨蜂毒肽对非小细胞肺癌转化生长因子β(TGF-β)/SMAD信号通路的调控作用及对TGF-β1诱导的上皮-间质转化(EMT)进程的影响。方法 通过外源性TGF-β1刺激构建非小细胞肺癌A549细胞EMT模型,将细胞分为对照组、TGF-β1组(加入2 μg/L TGF-β1)、蜂毒肽组(加入2.5 mg/L蜂毒肽)、蜂毒肽+TGF-β1组(加入2 μg/L TGF-β1和2.5 mg/L蜂毒肽)。采用免疫印迹及逆转录聚合酶链反应(RT-PCR)实验检测各组细胞EMT标志蛋白钙黏附蛋白E、N-钙黏蛋白、波形蛋白及mRNA表达情况;同时检测各组细胞中Smad2、p-Smad2蛋白表达情况,分析蜂毒肽对非小细胞肺癌TGF-β/SMAD信号通路的影响。采用免疫荧光实验检测对照组及蜂毒肽组细胞中TGF-βⅠ受体及TGF-βⅡ受体表达情况,同时采用Transwell实验检测两组细胞迁移、侵袭能力。结果 ①与对照组相比,TGF-β1组钙黏附蛋白E mRNA及蛋白表达水平明显降低,N-钙黏蛋白mRNA及蛋白与波形蛋白mRNA及蛋白表达水平明显升高(均P<0.05)。蜂毒肽+ TGF-β1组钙黏附蛋白EmRNA及蛋白表达水平明显优于TGF-β1组,且N-钙黏蛋白mRNA、蛋白以及波形蛋白mRNA、蛋白表达水平低于TGF-β1组(均P<0.05)。②对照组和蜂毒肽组细胞中TGF-βⅠ受体表达比较,差异无统计学意义(P>0.05),蜂毒肽组中TGF-βⅡ受体含量明显少于对照组。③Transwell实验结果显示,TGF-β1组细胞迁移、侵袭能力明显优于对照组,蜂毒肽+TGF-β1组细胞迁移、侵袭能力明显劣于TGF-β1组细胞(均P<0.05)。结论 蜂毒肽可通过抑制TGF-β/SMAD信号通路抑制Smad2磷酸化,下调TGF-βⅡ受体分布,从而抑制肿瘤细胞的侵袭、迁移,抑制TGF-β1诱导的肺癌细胞EMT进程。

    Abstract:

    Objective To investigate the regulatory effect of betulin on transforming growth factor-β/Smad signaling pathway and its effect on TGF-β1-induced epithelial-mesenchymal transition process of non-small cell lung cancer. Methods The EMT model of non-small cell lung cancer A549 cells was established by exogenous TGF-β1 stimulation. The cells were divided into control group, TGF-β1 group (adding 2 μg/L TGF-β1), melitotide group (adding 2.5 mg/L melitotide), TGF-β1+ melitotide group (adding 2 μg/L TGF-β1 and 2.5 mg/L melitotide). Western blotting and reverse transcription-polymerase chain reaction (RT-PCR) were used to detect the expression levels of EMT marker proteins calcadherin E, n-calcadherin, vimentin and their mRNA. Meanwhile, the protein expressions of Smad2 and p-Smad2 in each group were detected to analyze the effect of melitinin on TGF-β/ Smad signaling pathway in NSCLC. Using immunofluorescence experiments testing in the control group and TGF-βⅠ melittin group cells receptors and TGF-βⅡ receptor expression, at the same time the two groups of Transwell experiment testing cell migration, invasion ability. Results Compared with the control group, TGF-β1 group significantly decreased the expression levels of cadcadin emRNA and protein, and N-cadcadin mRNA and protein and vimentin mRNA and protein, the expression level was significantly increased ( P<0.05 ). The expression levels of cadherin emRNA and protein in melittin + TGF-β1 group were significantly higher than those in TGF-β1 group. N-cadherin mRNA and protein in melittin+TGF-β1 group were significantly higher than those in TGF-β1 group and vimentin mRNA, protein were lower than TGF-β1 group( P<0.05 ). In the control group and melittin group cells TGF, there was no statistically significant difference beta Ⅰ receptor expression( P>0.05 ), TGF-beta Ⅱ receptor content in melittin group obviously less than control group. Transwell test results showed that the cell migration and invasion ability of TGF-β1 group was significantly better than that of the control group cells and The cell migration and invasion ability of betinin +TGF-β1 group was significantly worse than that of TGF-β1 group ( P<0.05 ). Conclusion Melittin can inhibit TGF-β/SMAD signaling pathway, inhibit phosphorylation Smad2, reduce TGF-βⅡ receptors, inhibite the invasion and migration of tumor cells, and the EMT process of lung cancer cells induced by TGF-β1 was inhibited.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-12
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司